• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Professor Joann Sweasy

The focus of Professor Sweasy’s research is genomic instability and how it leads to the mutations that result in human diseases such as cancer. A major focus of the laboratory is to understand how single nucleotide polymorphisms found in DNA repair genes, including genes that function in homology directed repair (HDR), nonhomologous end-joining (NHEJ) and base excision repair (BER) in the germline and somatic tissues impact cancer risk and treatment. These and other studies impact scientists’ fundamental understanding of DNA repair and have the potential to lead to the design of targeted cancer therapeutics.

After receiving her B.A. from Beaver College, Sweasy became a staff scientist at Merck, Sharpe and Dohme Research Laboratories, where she worked on the development of Ivermectin, currently on the World Health Organization’s List of Essential Medicines. She earned a Ph.D. in microbiology at Rutgers University and conducted postdoctoral studies at the University of Washington. In 1993, Sweasy joined the Yale faculty as an assistant Professor of therapeutic radiology. Subsequently, she has held several academic and administrative appointments, including serving as a full Professor in the Departments of Therapeutic Radiology and Genetics, and associate Director for basic sciences at the Yale Comprehensive Cancer Center. Sweasy is also an adjunct Professor of microbiology and molecular genetics at the University of Vermont.

The Yale Professor has received research grants from the National Institute of Environmental Health Sciences, the National Cancer Institute, and the Blue Skye Foundation, among other institutions.

Sweasy has contributed numerous research articles, book chapters, and reviews to edited volumes and journals. She is on the editorial boards of Cancer Research, DNA Repair, and the Journal of Cellular Physiology. Sweasy has served as chair of the radiation, therapy and biology study section of the National Institutes of Health and is currently a member of the Cancer Etiology Study Section.

Sweasy’s honors include the Anna and Argall Hull Fellowship, the American Cancer Society Junior Faculty Research Award, and the 2016 Environmental Mutagenesis and Genomics Society Annual Award for scientific excellence. She received a Donaghue Investigator Award and is a member of the Connecticut Academy of Sciences and Engineering.

« Professor René Bernards
Professor John Hartley »

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 & Tuesday, 13 April 2021, Virtual Meeting

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info